Literature DB >> 33772049

Phosphoprotein enriched in astrocytes (PEA)-15 is a novel regulator of adipose tissue expansion.

Pola J Verschoor1, Fiona H Greig1, Justin J Rochford1,2, Giovanni Levate1, Mirela Delibegovic1, Dawn Thompson1, Alasdair Leeson-Payne2, Ruta Dekeryte1, Ruth Banks1, Joe W Ramos3, Graeme F Nixon4.   

Abstract

Excessive expansion of adipose tissue in obesity typically leads to overflow and accumulation of lipids in other tissues, causing fatty liver disease and atherosclerosis. The intracellular protein, phosphoprotein enriched in astrocytes (PEA)-15 has been linked to metabolic disease but its role in lipid storage has not been examined. To delineate the role of PEA-15 in adipose tissue, we placed PEA-15-/- mice on a high fat diet. These mice developed increased body weight and greater white adipose tissue expansion compared to high fat diet-fed wild type mice. This was due to increased adipocyte cell size in PEA-15-/- mice consistent with greater lipid storage capacity. Surprisingly, PEA-15-/- mice exhibited improvements in whole body insulin sensitivity, lower hepatic weight and decreased serum triglycerides indicating a protective phenotype. To determine effects on atherosclerosis, PEA-15-/- mice were crossed with the ApoE-/- mice on a high fat diet. Strikingly, these mice were protected from atherosclerosis and had less hepatic lipid accumulation despite increased adiposity. Therefore, we reveal for the first time that PEA-15 plays a novel role in regulating the expansion of adipose tissue. Decreasing PEA-15 expression increases the sequestering of lipids in adipose tissue, protecting other tissues in obesity, thereby improving metabolic health.

Entities:  

Year:  2021        PMID: 33772049      PMCID: PMC7997924          DOI: 10.1038/s41598-021-86250-x

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  43 in total

Review 1.  Frontiers: PED/PEA-15, a multifunctional protein controlling cell survival and glucose metabolism.

Authors:  Francesca Fiory; Pietro Formisano; Giuseppe Perruolo; Francesco Beguinot
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-06-16       Impact factor: 4.310

Review 2.  Nonalcoholic fatty liver disease and lipids.

Authors:  Anthony S Wierzbicki; Jude Oben
Journal:  Curr Opin Lipidol       Date:  2012-08       Impact factor: 4.776

3.  Obesity-associated improvements in metabolic profile through expansion of adipose tissue.

Authors:  Ja-Young Kim; Esther van de Wall; Mathieu Laplante; Anthony Azzara; Maria E Trujillo; Susanna M Hofmann; Todd Schraw; Jorge L Durand; Hua Li; Guangyu Li; Linda A Jelicks; Mark F Mehler; David Y Hui; Yves Deshaies; Gerald I Shulman; Gary J Schwartz; Philipp E Scherer
Journal:  J Clin Invest       Date:  2007-09       Impact factor: 14.808

Review 4.  The regulation of extracellular signal-regulated kinase (ERK) in mammalian cells.

Authors:  Joe W Ramos
Journal:  Int J Biochem Cell Biol       Date:  2008-05-15       Impact factor: 5.085

Review 5.  Death effector domain-containing proteins.

Authors:  M Gudur Valmiki; J W Ramos
Journal:  Cell Mol Life Sci       Date:  2009-03       Impact factor: 9.261

6.  The cell size and distribution of adipocytes from subcutaneous and visceral fat is associated with type 2 diabetes mellitus in humans.

Authors:  Lingling Fang; Fangjian Guo; Lihua Zhou; Richard Stahl; Jayleen Grams
Journal:  Adipocyte       Date:  2015-04-01       Impact factor: 4.534

Review 7.  Adipogenesis and metabolic health.

Authors:  Alexandra L Ghaben; Philipp E Scherer
Journal:  Nat Rev Mol Cell Biol       Date:  2019-04       Impact factor: 94.444

8.  ETO/MTG8 is an inhibitor of C/EBPbeta activity and a regulator of early adipogenesis.

Authors:  Justin J Rochford; Robert K Semple; Matthias Laudes; Keith B Boyle; Constantinos Christodoulides; Claire Mulligan; Christopher J Lelliott; Sven Schinner; Dirk Hadaschik; Meera Mahadevan; Jaswinder K Sethi; Antonio Vidal-Puig; Stephen O'Rahilly
Journal:  Mol Cell Biol       Date:  2004-11       Impact factor: 4.272

9.  Adipose specific disruption of seipin causes early-onset generalised lipodystrophy and altered fuel utilisation without severe metabolic disease.

Authors:  George D Mcilroy; Karla Suchacki; Anke J Roelofs; Wulin Yang; Yanyun Fu; Bo Bai; Robert J Wallace; Cosimo De Bari; William P Cawthorn; Weiping Han; Mirela Delibegović; Justin J Rochford
Journal:  Mol Metab       Date:  2018-01-31       Impact factor: 7.422

10.  PEA-15 (Phosphoprotein Enriched in Astrocytes 15) Is a Protective Mediator in the Vasculature and Is Regulated During Neointimal Hyperplasia.

Authors:  Fiona H Greig; Simon Kennedy; George Gibson; Joe W Ramos; Graeme F Nixon
Journal:  J Am Heart Assoc       Date:  2017-09-11       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.